IP Library › Granted Patent US 10,722,545
Granted Patent B2
US 10,722,545 · App. 15/859,692 · Granted Jul 28, 2020

Compound and method for treatment of movement disorders

Inventor: Alexander Kariman (Rockville, MD)
A61K36/185A61K9/0078A61K9/2009A61K9/4825A61K9/4858A61K47/44A61P25/16A61P25/32A61K31/01A61K31/355A61K31/56A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,722,545
App. No.
15/859,692
Granted
Jul 28, 2020
Kind
B2
Abstract

The disclosed invention generally relates to pharmaceutical compounds and methods for treating and/or preventing diseases and disorders that often manifest in hyper and/or hypokinetic movements symptoms, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids to subjects in need of treatment. The disclosed invention further relates to cannabinoid pharmaceutical compounds where said compound contains at least some non-cannabinoid components.

Claims (2)

1. A time release capsule consisting essentially of cannabis , micelles, methyl paraben, and glycerin.

2. A time release capsule consisting essentially of cannabis , micelles, ethyl paraben, and glycerin.

Continuity (1)
Related Publication 20190201463A1 · Jul 4, 2019
Cited By (1)
US 12,491,200